GDNF gene therapy in the N171-82Q transgenic mouse model of Huntington's disease

被引：0
|
作者：
McBride, JL
Ramaswamy, S
Bartus, RT
Gasmi, M
Brandon, E
Zhou, L
Barry-Kravis, E
Pitzer, MR
Chen, E
Kordower, JH
机构：
[1] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[2] Ceregene Inc, San Diego, CA USA
[3] Dominican Univ, Dept Psychol, River Forest, IL 60305 USA
来源：
EXPERIMENTAL NEUROLOGY | 2005年 / 193卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [21] Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
    Xi Chen
    Jun Wu
    Svetlana Lvovskaya
    Emily Herndon
    Charlene Supnet
    Ilya Bezprozvanny
    [J]. Molecular Neurodegeneration, 6
  • [22] Gene therapy using AAV-Neurturin (CERE-120) in a transgenic mouse model of Huntington's disease
    Ramaswamy, S.
    McBride, J. L.
    Zhou, L.
    Berry-Kravis, E.
    Herzog, C. D.
    Gasmi, M.
    Bartus, R. T.
    Kordower, J. H.
    [J]. CELL TRANSPLANTATION, 2007, 16 (03) : 341 - 341
  • [23] Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease
    Ebert, Allison D.
    Barber, Amelia E.
    Heins, Brittany M.
    Svendsen, Clive N.
    [J]. EXPERIMENTAL NEUROLOGY, 2010, 224 (01) : 155 - 162
  • [24] Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model
    Jiang, Wenxiao
    Wei, Wenjie
    Gaertig, Marta A.
    Li, Shihua
    Li, Xiao-Jiang
    [J]. PLOS ONE, 2015, 10 (07):
  • [25] Valproate increases the survival in a transgenic mouse model of Huntington's disease
    Klivenyi, P.
    Zadori, D.
    Geisz, A.
    Vamos, E.
    Vecsei, L.
    [J]. MOVEMENT DISORDERS, 2010, 25 (07) : S273 - S273
  • [26] Novel ethological endophenotypes in a transgenic mouse model of Huntington's disease
    Mo, Christina
    Renoir, Thibault
    Hannan, Anthony J.
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2015, 276 : 17 - 27
  • [27] The role of carnosine administration in a transgenic mouse model of Huntington's disease
    Plangar, I.
    Zadori, D.
    Klivenyi, P.
    Vecsei, L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 384 - 384
  • [28] In vivo mr studies in a transgenic mouse model of Huntington's disease
    Page, RA
    West, DA
    Dady, EB
    Thornton, JS
    Bates, GP
    Woodman, B
    Bainbridge, A
    Priest, AN
    Ordidge, RJ
    Davie, CA
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (02): : 232 - 232
  • [29] Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
    Ferrante, RJ
    Andreassen, OA
    Jenkins, BG
    Dedeoglu, A
    Kuemmerle, S
    Kubilus, JK
    Kaddurah-Daouk, R
    Hersch, SM
    Beal, MF
    [J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (12): : 4389 - 4397
  • [30] An Optimization of AAV-82Q-Delivered Rat Model of Huntington's Disease
    So, Kyoung-Ha
    Choi, Jai Ho
    Islam, Jaisan
    Elina, K. C.
    Moon, Hyeong Cheol
    Won, So Yoon
    Kim, Hyong Kyu
    Kim, Soochong
    Hyun, Sang-Hwan
    Park, Young Seok
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2020, 63 (05) : 579 - 589
12345